Melinda Elliott, MD

Chief Medical Officer

Dr. Elliott joined Prolacta in 2016 as Senior Director, Clinical Education and Professional Development and is currently the Chief Medical Officer (CMO). As CMO, she serves as the voice of the patient, working to ensure that the needs of premature infants are being articulated and that the relevant treatment and product opportunities are identified. She also continues to serve as a clinical neonatologist with the Mednax Medical Group.

Dr. Elliott earned her Medical Degree from West Virginia University School of Medicine. A champion for babies since the inception of her medical career, Dr. Elliott trained and taught extensively at the University of Florida, including residency training in Pediatrics, a faculty position as chief resident in pediatrics, and fellowship training in Neonatal-Perinatal Medicine. After holding professional and clinical positions at The Johns Hopkins Hospital, Union Memorial Hospital, and Franklin Square Hospital Center, Dr. Elliott joined the faculty at The Herman and Walter Samuelson Children’s Hospital at Sinai in Baltimore and the Mednax Medical Group.

Dr. Elliott has committed her career to the care of vulnerable, premature infants and has researched the benefits of an exclusive human milk-based diet for extremely low birth weight premature infants in the NICU. She has investigated breastfeeding practices of mothers of very low birth weight infants, including micro-preemies, and her clinical research is published in academic journals. Dr. Elliott is an experienced neonatologist, educator, mentor, and leader in neonatal intensive care.